Online citations, reference lists, and bibliographies.
← Back to Search

The Treatment Of Mitochondrial Myopathies And Encephalomyopathies.

P. Peterson
Published 1995 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
This paper briefly summarizes the results of a long-term, open pharmacotherapy trial in 16 patients with well-characterized mitochondrial disease. Outcome measures included repeated clinical evaluation, 31P-NMR spectroscopy and near-infrared spectroscopy. Treated patients appeared to survive longer with less functional disability and medical complications than typically seen in clinical practice.
This paper references
10.1016/0003-9861(68)90561-4
Biochemical studies of skeletal muscle mitochondria. I. Microanalysis of cytochrome content, oxidative and phosphorylative activities of mammalian skeletal muscle mitochondria.
M. Makinen (1968)
10.1016/b978-0-08-092440-3.50001-4
Methods in toxicology
G. Paget (1970)
10.1001/ARCHNEUR.1972.00490140078011
Lipid storage myopathy responsive to prednisone.
A. Engel (1972)
10.1016/S0140-6736(80)92006-1
β-BLOCKERS, AUTOIMMUNITY, AND RASHES
R. Staughton (1980)
10.1212/WNL.34.2.163
Adrenoleukodystrophy: Very long‐chain fatty acid metabolism in fibroblasts
W. Rizzo (1984)
10.1002/ANA.410190615
Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P‐NMR follow‐up study
Z. Argov (1986)
10.1212/WNL.37.2.257
Bioenergetic heterogeneity of human mitochondrial myopathies
Z. Argov (1987)
10.1016/s0021-9258(18)60978-0
Phosphorylation site of eukaryotic initiation factor 4E.
W. Rychlik (1987)
10.1146/ANNUREV.BI.56.070187.002143
Intracellular calcium homeostasis.
E. Carafoli (1987)
10.1002/ANA.410240507
Kearns‐sayre syndrome: Biochemical studies of mitochondrial metabolism
M. Martens (1988)
10.1111/j.1365-2990.1989.tb01214.x
MITOCHONDRIA–RELATED ENCEPHALOMYOPATHIES
H. Goebel (1989)
10.1007/978-3-642-74415-0
Molecular Basis of Membrane-Associated Diseases
A. Azzi (1989)
10.1016/0022-510X(90)90015-F
Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial
N. Bresolin (1990)
10.1289/EHP.9084107
The role of calcium ions in toxic cell injury.
J. Farber (1990)
10.1016/S0005-2728(05)80232-4
In vitro effects of glucocorticoid on mitochondrial energy metabolism.
M. Martens (1991)
10.1146/ANNUREV.BI.61.070192.005523
Diseases of the mitochondrial DNA.
D. Wallace (1992)
Handbook of cerebellar diseases
R. Lechtenberg (1993)



This paper is referenced by
10.1007/s40291-020-00510-6
Current and Emerging Clinical Treatment in Mitochondrial Disease
Rory J Tinker (2021)
10.1007/978-3-319-56210-0
Stroke Genetics
Pankaj Sharma (2017)
10.1097/MD.0000000000008716
Pulmonary hypertension as a manifestation of mitochondrial disease
Shan Xu (2017)
10.2174/1381612820666140306103401
Metabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases.
Yu-Ting Wu (2014)
10.1177/0883073814538509
Treatment of Mitochondrial Disorders
G. Enns (2014)
10.1016/j.gene.2012.12.024
Leigh syndrome associated with mitochondrial complex I deficiency due to novel mutations In NDUFV1 and NDUFS2.
Samantha E. Marin (2013)
10.1007/978-0-85729-209-4_10
Other Monogenetic Stroke Disorders
J. W. Cole (2013)
Selected Complications of Highly Active Antiretroviral Therapy in HIV Disease: An Overview for the Primary Care Provider
M. Todd (2012)
10.1016/j.mito.2011.05.002
Why are there no proven therapies for genetic mitochondrial diseases?
P. Stacpoole (2011)
10.1002/9781118148143.CH3
Oxidative Stress and its Biochemical Consequences in Mitochondrial DNA Mutation‐Associated Diseases: Implications of Redox Therapy for Mitochondrial Diseases
Shi-Bei Wu (2011)
10.1002/9780470034590.EMRSTM1106
Inherited Disease Studies by NMR
R. A. Iles (2010)
10.1097/WNO.0b013e3181e014c8
Mitochondrial pseudomyasthenia.
J. Barton (2010)
10.1111/j.1365-2265.2008.03341.x
MELAS syndrome, diabetes and thyroid disease: the role of mitochondrial oxidative stress
T. Tan (2009)
10.1016/j.urology.2007.11.074
Effect of co-enzyme Q10 and alpha-lipoic acid on response of rabbit urinary bladder to repetitive stimulation and in vitro ischemia.
Wei-Yu Lin (2008)
10.1111/j.1464-5491.2008.02359.x
Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation
R. Murphy (2008)
10.1016/j.addr.2008.05.001
The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies.
M. Tarnopolsky (2008)
10.3803/JKES.2008.23.6.444
A Case of MELAS Syndrome Manifested by Insulin-deficient Diabetes Mellitus
Hee seog Jeong (2008)
10.1016/B978-0-7506-7525-3.50069-8
Vascular Diseases of the Nervous System
J. Biller (2008)
10.1002/mus.20688
Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders
M. C. Rodriguez (2007)
10.1117/1.2805437
Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans.
T. Hamaoka (2007)
10.1016/J.MITO.2007.03.008
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
R. Haas (2007)
10.1157/13099580
Tratamiento antirretroviral y toxicidad mitocondrial
E. S. Corraliza (2007)
10.1016/J.PEDIATRNEUROL.2006.05.012
Treatment of mitochondrial encephalomyopathies with a xanthine oxidase inhibitor.
M. Castro‐Gago (2006)
Beneficial Effects of Nutraceutical Cofactor Therapy in Patients with Mitochondrial Disorders
M. C. Rodriguez (2006)
10.1016/J.YJMCC.2005.03.017
Effects of menadione and its derivative on cultured cardiomyocytes with mitochondrial disorders.
V. Shneyvays (2005)
10.1016/j.jns.2004.11.014
Magnetic resonance spectroscopy in patients with MELAS
H. Möller (2005)
10.4065/80.1.122
Genetics of cerebrovascular disorders.
J. Meschia (2005)
Interruption of antiretroviral treatment in HIV-infected children
U. Gerlach (2004)
10.1016/J.YMGME.2003.12.008
Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders.
B. Marriage (2004)
10.1097/00000441-200407000-00007
Metabolic Complications Associated with the Use of Highly Active Antiretroviral Therapy in HIV-1–Infected Adults
P. Monier (2004)
10.1023/B:BOLI.0000037354.66587.38
Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases
J. Panetta (2004)
10.1016/S0076-6879(04)82026-3
Therapeutic effects of coenzyme Q10 in neurodegenerative diseases.
M. Beal (2004)
See more
Semantic Scholar Logo Some data provided by SemanticScholar